Literature DB >> 20028495

Successful living donor liver transplantation for severe hepatic GVHD histologically resembling autoimmune hepatitis after bone marrow transplantation from the same sibling donor.

Minako Mori1, Sumie Tabata, Hisako Hashimoto, Daichi Inoue, Takaharu Kimura, Sonoko Shimoji, Yuya Nagai, Katsuhiro Togami, Kiminari Itoh, Akiko Matsushita, Kenichi Nagai, Eiji Ikeda, Naoya Kimoto, Kenji Uryuhara, Satoru Kaihara, Yukihiro Imai, Masafumi Itoh, Takayuki Takahashi.   

Abstract

A 30-year-old woman developed severe liver dysfunction 1 year after bone marrow transplantation (BMT) from an HLA-identical sibling donor for B lymphoblastic leukemia (B-ALL) during the tapering of cyclosporin A. The histologic picture resembled autoimmune hepatitis (AIH), although neither autoantibody nor hypergammaglobulinemia was detected. She entered hepatic coma, and underwent living donor liver transplantation from the same donor on day 421 after BMT. She is well 18 months after the procedure, showing normal liver function and hematopoiesis. AIH-like hepatic graft-versus-host disease (GVHD) has not been documented. This patient is the second case of living donor liver transplantation for hepatic GVHD from the same donor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20028495     DOI: 10.1111/j.1432-2277.2009.01028.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  2 in total

1.  Autoimmune-like hepatitis after allogeneic hematopoietic stem cell transplantation: humoral hepatic GvHD.

Authors:  D Koyama; M Ito; E Yokohata; K Watakabe; K Onodera; T Goto; A Seto; K Watanabe; M Doisaki; Y Ozawa; T Yamaguchi; K Miyamura
Journal:  Bone Marrow Transplant       Date:  2016-08-15       Impact factor: 5.483

Review 2.  Successful treatment of severe refractory hepatic graft-versus-host disease by cadaveric liver transplant.

Authors:  Amer M Zeidan; Jocelyn L Wozney; Michael Torbenson; Karen Krok; Javier Bolaños-Meade
Journal:  Leuk Lymphoma       Date:  2013-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.